As high-deductible plans proliferate and regulators step up scrutiny of hospital collection practices, some providers are investing in tools to make the process less confusing and easier to navigate and using sophisticated algorithms to predict who is most likely to pay.
It's a tough challenge to engage academic physicians in managing the health of an enrolled patient population.
Connecting monitoring devices and EHRs is likely to become a growth business over the next decade. Once they do start communicating, together they could also help clinicians improve care and raise hospital productivity.
The personalized medicine marketing wars are on. From national chains to regional powers, hospital systems are spending millions of dollars to claim leadership in this new field.
A growing number of hospitals have turned to healthcare consulting firms for help to streamline and improve their clinical operations. Increased financial pressures associated with declining inpatient volume, rate pressure from insurers, and Medicare performance-based rewards and penalties have...
Total compensation for some of the highest-paid CEOs in the healthcare industry increased faster than their companies' profits last year, a Modern Healthcare analysis of the first firms to report executive pay found.
For women who aspire to healthcare's executive-level roles, advanced education and the willingness to take risks may not be enough. Surveys of corporate leadership and healthcare management point to a continued, though narrowing, disparity of women to men in leadership roles.
To select Modern Healthcare's sixth biennial list of the Top 25 Women in Healthcare, sponsored by Furst Group, the magazine started with more than 200 nominations submitted between Dec. 15, 2014, and...
Welcoming women executives to your leadership team is a prudent thing to do because a diversity of opinions and experiences can make your organization only stronger.
Efforts to effectively manage patients after they've been discharged is a key feature distinguishing high-performing health systems from their peers in Truven Health Analytics' seventh annual ranking of top-performing systems.
Approval by the Food and Drug Administration of the new PCSK9 inhibitors would be an enormous boon to the drugmakers that developed them.
If left untreated, Stacey Lane's level of bad cholesterol would soar to more than four times what heart experts recommend. Help for her genetic disorder could come in the form of a new category of injectable drugs known as PCSK9 inhibitors, but it won't be cheap.